http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1230875-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-16 |
| filingDate | 1986-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1987-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1987-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1230875-A |
| titleOfInvention | Bicyclic nitrogen heterocyclic ethers and thioethers, and their pharmaceutical uses |
| abstract | ABSTRACT OF THE DISCLOSURE The invention relates to a class of bicyclic nitrogen heterocyclic ether and thioether compounds having the general formula: wherein: W1 is CH, CH2, CHR or CR; W2 and W3 are independently CH, CH2, CHR3 or CR3; X is N or CH, or (CH)3-d, when Y is (CH)d; Y is O, S, or NR4, or (CH)d, when X is (CH)3-d; Z is O, S, , , or CH2; and wherein: R is alkyl, halo, alkoxy, hydroxy, hydroxy alkyl, halo alkyl, -(CH2)n-NR8R9, , or ; R1 is H, alkyl, acyl, haloalkyl, alkoxy alkyl, hydroxyalkyl, aminoalkyl, mono- and di-alkylamino alkyl, or together with W1 forms a carbon-nitrogen double bond; R2 is selected from the group consisting of NH2, , , , , , and ; R3 is alkyl, halo, alkoxy, hydroxy, hydroxy alkyl, haloalkyl, aminoalkyl, mono- and di-alkylamino alkyl, amino, alkylamino, or dialkylamino; R4 is H, alkyl, or acyl; R5 is H or alkyl; R6 is H, alkyl or acyl; R8 and R9 are each independently hydrogen, alkyl, or both together with the nitrogen to which they are attached form a 5, 6 or 7-membered ring which may in-clude one to three additional hetero atoms of N, O or S; and wherein: a is 0 or 1; b is 1 or 2; c is 0, 1 or 2; d is 0, 1, 2 or 3; e is 1 or 2; f is 1, 2, 3, or 4; n is 0, 1, 2, or 3; and the acid addition salts thereof. These compounds exhibit physiological activity in mammals including anti-secretory activity, histamine H2-receptor antagonist activity, anti-ulcer activity and cytoprotective activity. |
| priorityDate | 1982-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 173.